Live Quote · NASDAQABVCHealthcare· Biotechnology

ABVC BioPharma, Inc.

$1.80 1.69%(+$0.03)
TickerSpark Score
51/100
Mixed
60
Valuation
60
Profitability
35
Growth
52
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ABVC research report →

52-Week Range20% of range
Low
$0.88
Current
$1.80
High
$5.48
Company Overviewwww.abvcpharma.com

About the company

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on creating novel drugs and medical devices to address critical, underserved healthcare requirements across the United States. The company's pipeline includes several key candidates: ABV-1501, currently undergoing Phase I/II clinical trials, is being developed as a combination treatment for triple-negative breast cancer.

CEO
Uttam Yashwant Patil
IPO
2004
Employees
16
HQ
Fremont, CA, US

Price Chart

-41.94% · this period
$4.74$2.82$0.91Jul 02Dec 31Jul 02
Valuation
Market Cap
$26.08M
P/E
-15.67
P/S
-32.77
P/B
4.25
EV/EBITDA
-3.13
Div Yield
0.00%
Profitability
Gross Margin
100.00%
Op Margin
1108.95%
Net Margin
1183.83%
ROE
-92.03%
ROIC
-56.73%
Growth & Income
Revenue
$0 · -100.00%
Net Income
$-7,908,554 · -61.30%
EPS
$-0.39 · 7.14%
Op Income
$-7,151,259
FCF YoY
-65.07%
Performance & Tape
52W High
$5.48
52W Low
$0.88
50D MA
$1.25
200D MA
$1.93
Beta
0.57
Avg Volume
135.36K

Get TickerSpark's AI analysis on ABVC

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
May 20, 22Jiang Shulingother0
Aug 2, 21An Chihliangother0
Aug 2, 21Sakamoto Norimiother0
Aug 2, 21Odaira Yoshinobuother0
Aug 2, 21Jiang Tsung Shannother0
Aug 2, 21Miao Shin-Yuother0
Nov 8, 21Tseng Shih-Chenother0
Aug 2, 21Jiang Eugeneother0
Aug 2, 21Jiang Chang-Jenother0
Aug 2, 21King Chi-Hsin Richardother0
Coverage · ABVC

Our ABVC coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on ABVC yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate ABVC report →
Internal Compare

Similar companies

Peers in the same neighborhood.